Search Results - "Lestner, Jodi M."

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring by Lestner, Jodi M., Roberts, Steven A., Moore, Caroline B., Howard, Susan J., Denning, David W., Hope, William W.

“…We explored concentration-toxicity relationships for itraconazole among 216 patients. Logistic regression revealed a progressive increase in the probability of…”
Get full text

Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis by LESTNER, Jodi M, HOARD, Susan J, GOODWIN, Joanne, GREGSON, Lea, MAJITHIYA, Jayesh, WALSH, Thomas J, JENSEN, Gerard M, HOPE, William W

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Delineating the 17q24.2–q24.3 microdeletion syndrome phenotype by Lestner, Jodi M, Ellis, Richard, Canham, Natalie

“…Abstract We present an 11-year-old girl with a 2.3 Mb de novo interstitial deletion in chromosome 17q24.2–q24.3 identified by array CGH. The phenotype in this…”
Get full text

Vancomycin toxicity in neonates: a review of the evidence by Lestner, Jodi M, Hill, Louise F, Heath, Paul T, Sharland, Mike

“…PURPOSE OF REVIEWVancomycin is a first-line agent in the treatment of serious Gram-positive infections in the neonatal population. The published evidence on…”
Get full text

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy by Howard, Susan J., Lestner, Jodi M., Sharp, Andrew, Gregson, Lea, Goodwin, Joanne, Slater, Joanne, Majithiya, Jayesh B., Warn, Peter A., Hope, William W.

“…Background. Posaconazole is a triazole with anti-Aspergillus activity. However, little is known about the utility of posaconazole as primary therapy for…”
Get full text

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children by Lestner, Jodi M, Groll, Andreas H, Aljayyoussi, Ghaith, Seibel, Nita L, Shad, Aziza, Gonzalez, Corina, Wood, Lauren V, Jarosinski, Paul F, Walsh, Thomas J, Hope, William W

“…Liposomal amphotericin B (LAmB) is widely used in the treatment of invasive fungal disease (IFD) in adults and children. There are relatively limited…”
Get full text

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology by Barker, Charlotte I.S., Germovsek, Eva, Hoare, Rollo L., Lestner, Jodi M., Lewis, Joanna, Standing, Joseph F.

“…Pharmacokinetic/pharmacodynamic (PKPD) modelling is used to describe and quantify dose–concentration–effect relationships. Within paediatric studies in…”
Get full text

Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective by Lestner, Jodi M., Smith, P. Brian, Cohen‐Wolkowiez, Michael, Benjamin, Daniel K., Hope, William W.

“…Invasive fungal infections, although relatively rare, are life‐threatening diseases in premature infants and immunocompromised children. While many advances…”
Get full text

Tremor: a newly described adverse event with long-term itraconazole therapy by Lestner, Jodi M, Denning, David W

“…Itraconazole is a widely prescribed triazole antifungal drug, often given for long periods. The authors report five cases of tremor related to itraconazole…”
Get full text